Voxel‐wise longitudinal changes between amyloid PET and executive function subcomponents at the preclinical stage of the Alzheimer's continuum

Subtle cognitive decline across core EF subcomponents-attention, cognitive control, and working memory-was associated with distinct regional patterns of amyloid accumulation in CU individuals. These distinctive change-on-change signatures offer insights into the specific brain regions implicated in AD-related EF decline and underscore the importance of tailored neuropsychological assessments for monitoring subtle cognitive changes in preclinical AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70857_099274
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Voxel‐wise longitudinal changes between amyloid PET and executive function subcomponents at the preclinical stage of the Alzheimer's continuum

Gemma Salvadó, Gwendlyn Kollmorgen, Kaj Blennow, Carolina Minguillón et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Voxel‐wise longitudinal changes between amyloid PET and executive function subcomponents at the preclinical stage of the Alzheimer's continuum

Gemma Salvadó, Gwendlyn Kollmorgen, Kaj Blennow, Carolina Minguillón, David López‐Martos, for the ALFA study, Gonzalo Sánchez‐Benavides, Oriol Grau‐Rivera, Marta Milà‐Alomà, Henrik Zetterberg, Marc Suárez‐Calvet, Juan Domingo Gispert, Mahnaz Shekari
article en

Abstract

Subtle cognitive decline across core EF subcomponents-attention, cognitive control, and working memory-was associated with distinct regional patterns of amyloid accumulation in CU individuals. These distinctive change-on-change signatures offer insights into the specific brain regions implicated in AD-related EF decline and underscore the importance of tailored neuropsychological assessments for monitoring subtle cognitive changes in preclinical AD.

Alzheimer s & DementiaVol. 21(S3)
University of Wisconsin–Madison (US), University of California, San Francisco (US), Lund University (SE), Sahlgrenska University Hospital (SE), Instituto de Salud Carlos III (ES), Roche Pharma AG (Germany) (DE), Pasqual Maragall Foundation (ES), UK Dementia Research Institute (GB), Barcelonaβeta Brain Research Center (ES), Hospital Del Mar (ES), Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (ES), Northern California Institute for Research and Education (US), University College London (GB), University of Gothenburg (SE)
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.